QrumPharma Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

QrumPharma General Information

Description

Operator of a pharmaceutical company developing inhalation treatments for severe chronic and recurrent pulmonary infections. The company is developing a drug for the treatment of Nontuberculous Mycobacteria (NTM) and Tuberculosis.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Parent Company
Primary Office
  • 215 Decatur Street
  • Doylestown, PA 18901
  • United States
+1 (215) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

QrumPharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore QrumPharma‘s full profile, request access.

Request a free trial